Table 1 Levels of markers of oxidative stress in serum and plasma of controls and BC patients
From: High density lipoproteins and oxidative stress in breast cancer
Markers oxidative stress | Control | BC patients | Reference |
|---|---|---|---|
Serum lipid hydroperoxides (μmol/L) | 1.08 ± 0.24 | 1.97 ± 0.50 | [58] |
Plasma lipid hydroperoxides (nmol/mL) | 43.13 ± 9.12 | 58.23 ± 07.12 | [59] |
Serum malondialdehyde (nmol/mL) | 1.92 ± 0.12 | 3.77 ± 0.25 | [60] |
Serum malondialdehyde (μmol/L) | 2.72 ± 0.22 | 3.64 ± 0.25 | [61] |
TBARS (μmol/L) | 2.24 ± 0.83 | 2.62 ± 0.96 | [56] |
OxLDL (U/L) | 78.8 ± 56.1 | 288.3 ± 262.3 | [61] |
Ex-vivo susceptibility of serum lipids to oxidation (OD/sec) | 9.89*10−5 ± 3.36*10− 5 | 13.33*10− 5 ± 1.35*10− 5 | |
Anti-oxLDL autoantibodies (U/L) | 466.1 ± 495.7 | 737.9 ± 388.8 |